{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:05:09Z","timestamp":1792800309510,"version":"4.5.0"},"reference-count":47,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Hospital Pharmaceutical Research Fund of Guangdong Provincial Hospital Association","award":["YXKY202208"],"award-info":[{"award-number":["YXKY202208"]}]},{"DOI":"10.13039\/501100003785","name":"Medical Research Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["C2022073"],"award-info":[{"award-number":["C2022073"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2019A1515110148"],"award-info":[{"award-number":["2019A1515110148"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2020-04-1"],"award-info":[{"award-number":["320.6750.2020-04-1"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Immunopathol Pharmacol"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>Currently, no glucocorticoid dose prediction model is available for clinical practice. This study aimed to utilise machine learning techniques to develop and validate personalised dosage models. Participants were patients with SLE who were registered at Nanfang Hospital and received prednisone. Univariate analysis was used to confirm the feature variables. Subsequently, the random forest (RF) algorithm was utilised to interpolate the absent values of the feature variables. Finally, we assessed the prediction capabilities of 11 machine learning and deep-learning algorithms (Logistic, SVM, RF, Adaboost, Bagging, XGBoost, LightGBM, CatBoost, MLP, and TabNet). Finally, a confusion matrix was used to validate the three regimens. In total, 129 patients met the inclusion criteria. The XGBoost algorithm was selected as the preferred method because of its superior performance, achieving an accuracy of 0.81. The factors exhibiting the highest correlation with the prednisone dose were CYP3A4 (rs4646437), albumin (ALB), haemoglobin (HGB), anti-double-stranded DNA antibodies (Anti-dsDNA), erythrocyte sedimentation rate (ESR), age, and HLA-DQA1 (rs2187668). Based on validation, the precision and recall rates for low-dose prednisone (\u2a7e5\u2009mg but &lt;7.5\u2009mg\/d) were 100% and 40% respectively. Similarly, for medium-dose prednisone (\u2a7e7.5\u2009mg but &lt;30\u2009mg\/d), the accuracy and recall rates were 88% and 88%, and for high-dose prednisone (\u2a7e30\u2009mg but \u2a7d100\u2009mg\/d), the accuracy and recall rates were 62% and 100% respectively. A robust machine learning model was developed to accurately predict prednisone dosage by integrating the identified genetic and clinical factors.<\/jats:p>","DOI":"10.1177\/03946320251331791","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T05:34:02Z","timestamp":1743831242000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction and evaluation of glucocorticoid dose prediction model based on genetic and clinical characteristics of patients with systemic lupus erythematosus"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0575-6429","authenticated-orcid":false,"given":"Xin","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China"},{"name":"Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Zou","sequence":"additional","affiliation":[{"name":"Overseas Patient Center, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China"},{"name":"Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meida","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Trauma and Joint Surgery, Shunde Hospital, Southern Medical University, Foshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China"},{"name":"Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China"},{"name":"Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfei","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqian","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China"},{"name":"Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00668-1"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex444"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa403","article-title":"Treating systemic lupus erythematosus in the 21st century: New drugs and new perspectives on old drugs","volume":"59","author":"Ruiz-Irastorza G","year":"2020","unstructured":"Ruiz-Irastorza G, Bertsias G (2020) Treating systemic lupus erythematosus in the 21st century: New drugs and new perspectives on old drugs. Rheumatology (Oxford) 59(Suppl5): v69\u2013v81.","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.09.004"},{"issue":"1","key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1038\/s41598-019-46039-5","article-title":"Associated clinical factors for serious infections in patients with systemic lupus erythematosus","volume":"9","author":"Jung JY","year":"2019","unstructured":"Jung JY, Yoon D, Choi Y, et al. (2019) Associated clinical factors for serious infections in patients with systemic lupus erythematosus. Scientific Reports 9(1): 9704.","journal-title":"Scientific Reports"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570161118666191227101636"},{"issue":"3","key":"e_1_3_3_8_2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/JBMR.041125","article-title":"Effects of low-dose prednisone on bone metabolism","volume":"20","author":"Ton FN","year":"2005","unstructured":"Ton FN, Gunawardene SC, Lee H, et al. (2005) Effects of low-dose prednisone on bone metabolism. Journal of Bone and Mineral Research 20(3): 464\u2013470.","journal-title":"Journal of Bone and Mineral Research"},{"issue":"10","key":"e_1_3_3_9_2","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.526","article-title":"Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients","volume":"11","author":"Kaneko K","year":"2021","unstructured":"Kaneko K, Chen H, Kaufman M, et al. (2021) Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients. Clinical and Translational Medicine 11(10): e526.","journal-title":"Clinical and Translational Medicine"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez584"},{"issue":"1","key":"e_1_3_3_11_2","first-page":"1","article-title":"Impact of glucocorticoids on the incidence of lupus-related major organ damage: A systematic literature review and meta-regression analysis of longitudinal observational studies","volume":"8","author":"Ugarte-Gil MF","year":"2021","unstructured":"Ugarte-Gil MF, Mak A, Leong J, et al. (2021) Impact of glucocorticoids on the incidence of lupus-related major organ damage: A systematic literature review and meta-regression analysis of longitudinal observational studies. Lupus Science & Medicine 8(1): 1\u201310.","journal-title":"Lupus Science & Medicine"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-020-00827-8"},{"issue":"1","key":"e_1_3_3_13_2","article-title":"Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: A cross-sectional study","volume":"9","author":"Sada KE","year":"2022","unstructured":"Sada KE, Katayama Y, Asano Y, et al. (2022) Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: A cross-sectional study. Lupus Science & Medicine 9(1): e000772.","journal-title":"Lupus Science & Medicine"},{"issue":"1","key":"e_1_3_3_14_2","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000303","article-title":"10 most important contemporary challenges in the management of SLE","volume":"6","author":"Felten R","year":"2019","unstructured":"Felten R, Sagez F, Gavand PE, et al. (2019) 10 most important contemporary challenges in the management of SLE. Lupus Science & Medicine 6(1): e000303.","journal-title":"Lupus Science & Medicine"},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-pharmtox-010510-100502","article-title":"Omics and drug response","volume":"53","author":"Meyer UA","year":"2013","unstructured":"Meyer UA, Zanger UM, et al. (2013) Omics and drug response. Annual Review of Pharmacology and Toxicology 53: 475\u2013502.","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"4","key":"e_1_3_3_16_2","first-page":"727","article-title":"Machine learning: A new approach for dose individualization","volume":"115","author":"Li QY","year":"2023","unstructured":"Li QY, Tang BH, Wu YE, et al. (2023) Machine learning: A new approach for dose individualization. Clinical Pharmacology & Therapeutics 115(4): 727\u2013744.","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01155"},{"issue":"11","key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/jcm7110428","article-title":"Prediction of acute kidney injury after liver transplantation: Machine learning approaches vs. logistic regression model","volume":"7","author":"Lee HC","year":"2018","unstructured":"Lee HC, Yoon SB, Yang SM, et al. (2018) Prediction of acute kidney injury after liver transplantation: Machine learning approaches vs. logistic regression model. Journal of Clinical Medicine 7(11): 428.","journal-title":"Journal of Clinical Medicine"},{"issue":"10","key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00439-012-1194-y","article-title":"Risk estimation and risk prediction using machine-learning methods","volume":"131","author":"Kruppa J","year":"2012","unstructured":"Kruppa J, Ziegler A, Konig IR (2012) Risk estimation and risk prediction using machine-learning methods. Human Genetics 131(10): 1639\u20131654.","journal-title":"Human Genetics"},{"issue":"1","key":"e_1_3_3_20_2","article-title":"Evaluating the state of the art in missing data imputation for clinical data","volume":"23","author":"Luo Y","year":"2022","unstructured":"Luo Y (2022) Evaluating the state of the art in missing data imputation for clinical data. Briefings in Bioinformatics 23(1): bbab489.","journal-title":"Briefings in Bioinformatics"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.9b00633"},{"issue":"3","key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1515\/cclm-2019-0534","article-title":"Highly accurate and explainable detection of specimen mix-up using a machine learning model","volume":"58","author":"Mitani T","year":"2020","unstructured":"Mitani T, Doi S, Yokota S, et al. (2020) Highly accurate and explainable detection of specimen mix-up using a machine learning model. Clinical Chemistry and Laboratory Medicine 58(3): 375\u2013383.","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"1","key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s12967-023-04175-7","article-title":"Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases","volume":"21","author":"Saber R","year":"2023","unstructured":"Saber R, Henault D, Messaoudi N, et al. (2023) Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases. Journal of Translational Medicine 21(1): 507.","journal-title":"Journal of Translational Medicine"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-020-00369-8"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"813117","DOI":"10.3389\/fmed.2022.813117","article-title":"A Prediction model for tacrolimus daily dose in kidney transplant recipients with machine learning and deep learning techniques","volume":"9","author":"Zhang Q","year":"2022","unstructured":"Zhang Q, Tian X, Chen G, et al. (2022) A Prediction model for tacrolimus daily dose in kidney transplant recipients with machine learning and deep learning techniques. Frontiers in Medicine (Lausanne) 9: 813117.","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"890221","DOI":"10.3389\/fphar.2022.890221","article-title":"An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques","volume":"13","author":"Zheng P","year":"2022","unstructured":"Zheng P, Yu Z, Mo L, et al. (2022) An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques. Frontiers in Pharmacology 13: 890221.","journal-title":"Frontiers in Pharmacology"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/ard.46.10.773","article-title":"A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment","volume":"46","author":"Edwards JC","year":"1987","unstructured":"Edwards JC, Snaith ML, Isenberg DA (1987) A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment. Annals of the Rheumatic Diseases 46: 773\u2013776.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"e_1_3_3_28_2","first-page":"57","article-title":"Flares in lupus- outcome assessment trial (FLOAT), a comparison between oral 2006 methylprednisolone and intramuscular triamcinolone","volume":"33","author":"Adriana Danowski LM","year":"2006","unstructured":"Adriana Danowski LM, Petri M (2006) Flares in lupus- outcome assessment trial (FLOAT), a comparison between oral 2006 methylprednisolone and intramuscular triamcinolone. The Journal of Rheumatology 33(1): 57\u201366.","journal-title":"The Journal of Rheumatology"},{"issue":"20","key":"e_1_3_3_29_2","first-page":"1484","article-title":"Efficacy and safety of enteric coated","author":"Zeher M","year":"2011","unstructured":"Zeher M, Doria A, Lan J, et al. (2011) Efficacy and safety of enteric coated. Lupus (20): 1484\u20131493.","journal-title":"Lupus"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110866"},{"issue":"1","key":"e_1_3_3_31_2","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2016-000153","article-title":"First month prednisone dose predicts prednisone burden during the following 11 months: An observational study from the RELES cohort","volume":"3","author":"Ruiz-Irastorza G","year":"2016","unstructured":"Ruiz-Irastorza G, Garcia M, Espinosa G, et al. (2016) First month prednisone dose predicts prednisone burden during the following 11 months: An observational study from the RELES cohort. Lupus Science & Medicine 3(1): e000153.","journal-title":"Lupus Science & Medicine"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.05.011"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.10.013"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203205"},{"issue":"2","key":"e_1_3_3_35_2","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002701","article-title":"Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: The real-world GULP prospective observational study","volume":"8","author":"Floris A","year":"2022","unstructured":"Floris A, Chessa E, Sebastiani GD, et al. (2022) Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: The real-world GULP prospective observational study. RMD Open 8(2): e002701.","journal-title":"RMD Open"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-008-2291-6"},{"issue":"2","key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/17512433.2020.1702877","article-title":"Steroid-resistant nephrotic syndrome: Pharmacogenetics and epigenetic points and views","volume":"13","author":"Hejazian SM","year":"2020","unstructured":"Hejazian SM, Zununi Vahed S, Moghaddas Sani H, et al. (2020) Steroid-resistant nephrotic syndrome: Pharmacogenetics and epigenetic points and views. Expert Review of Clinical Pharmacology 13(2): 147\u2013156.","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"5","key":"e_1_3_3_38_2","first-page":"615","article-title":"Cyp3A regulation: From pharmacology to nuclear receptors","volume":"29","author":"Quattrochi LC","year":"2001","unstructured":"Quattrochi LC, Guzelian PS (2001) Cyp3A regulation: From pharmacology to nuclear receptors. Drug Metabolism and Disposition 29(5): 615\u2013622.","journal-title":"Drug Metabolism and Disposition"},{"key":"e_1_3_3_39_2","first-page":"1441","article-title":"Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: Consequences on cytochrome P450","volume":"58","author":"Pascussi JM","year":"2000","unstructured":"Pascussi JM, Gerbal-Chaloin S, Fabre JM, et al. (2000) Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: Consequences on cytochrome P450 Gene Regulation 58: 1441\u20131450.","journal-title":"Gene Regulation"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.5.443"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12708"},{"issue":"2","key":"e_1_3_3_42_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2215\/CJN.05310513","article-title":"HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy","volume":"9","author":"Bullich G","year":"2014","unstructured":"Bullich G, Ballar\u00edn J, Oliver A, et al. (2014) HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy. Clinical Journal of the American Society of Nephrology 9(2): 335\u2013343.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.39"},{"issue":"1","key":"e_1_3_3_44_2","article-title":"Combining C reactive protein and serum albumin to predict 90-day mortality in systemic lupus erythematosus with serious community-acquired infections","volume":"8","author":"He S","year":"2021","unstructured":"He S, Tang C, Yu J, et al. (2021) Combining C reactive protein and serum albumin to predict 90-day mortality in systemic lupus erythematosus with serious community-acquired infections. Lupus Science & Medicine 8(1): e000505.","journal-title":"Lupus Science & Medicine"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314530792"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102374"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102861"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24740"}],"container-title":["International Journal of Immunopathology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03946320251331791","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03946320251331791","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03946320251331791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:01:06Z","timestamp":1777456866000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03946320251331791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":47,"alternative-id":["10.1177\/03946320251331791"],"URL":"https:\/\/doi.org\/10.1177\/03946320251331791","relation":{},"ISSN":["0394-6320","2058-7384"],"issn-type":[{"value":"0394-6320","type":"print"},{"value":"2058-7384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"article-number":"03946320251331791"}}